Transaction · 0001797826-26-000006

Thornberry Nancy

Thornberry Nancy, DIR, reported an open-market or private sale at Denali Therapeutics Inc. involving 10824.000000 shares for an estimated $247328.40. Reported holdings after the transaction were 20301.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
DNLIDenali Therapeutics Inc.
Trade date
Sep 02, 2026
Filing date
Sep 04, 2026
View on SEC Insider profile
Estimated value-$247kShares × reported price
Shares traded10.8k$22.85 per share
Holdings after20.3kDirect
% of reported position traded34.78%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 31,125 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

DNLI price since this filing

Daily closing prices, with the filing date and available return windows
DNLI · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +3.9%1w ago +10.3%1d ago +4.4%
Returns since7d -5.3%30d -10.2%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001797826-26-000006
Common Stock
Transaction date
Sep 02, 2026
Filed Sep 04, 2026, 09:02 PM · 2d delay
Shares
10,824 sh
$22.85 per share
Estimated value
-$247k
Computed from shares × price
Holdings after
20,301 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Large Holdings Reduction 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted June 3, 2026.

  2. F2

    The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.54 to $23.52 per share. Upon request by the Commission staff, the Issuer, or a…

  3. F3

    Includes 6,408 Unvested RSUs.

  4. F4

    The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.59 to $23.85 per share. Upon request by the Commission staff, the Issuer, or a…

Original filing · 0001797826-26-000006
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

DNLI